AtriCure, Inc. ATRC
Set alert
59.88 USD -1.37 -2.24%
At close · Nov 2
58.75 -1.13 -1.89%
After hours · Nov 2, 5:40 PM ET
59.14 Day range 62.33
25.86 52-week range 62.48
- YTD
- +51.37%
- 1 year
- +73.31%
- Open
- 61.70
- Prev close
- 61.25
- Mkt cap
- 3.05B
- Vol
- 1.12M
- Avg vol
- 1.01M
- EPS
- 0.21
- P/E
- 285.14
- Div yield
- 0.00%
More statistics
- Low
- 59.14
- High
- 62.33
- Forward P/E
- 137.98
- Beta
- 1.21
- Short ratio
- 3.46
- Inst. own
- 106.75%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 3, 2026
- 50-d avg
- 55.58
- 200-d avg
- 38.09
- 1y target
- 57.56
Analyst view
Consensus: buy
Buy
Price target (mean) 57.56 -3.9% downside
Now 59.88
- Target (low)
- 36.00
- Target (mean)
- 57.56
- Target (high)
- 68.00
Ratings (0m) 10 7 buy · 3 hold · 0 sell
- Strong buy3
- Buy4
- Hold3
- Sell0
- Strong sell0
Recommendation trend
- This month 10
- 1 month ago 10
- 2 months ago 10
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.01192 | -0.03 – 0.05 | -0.01 | +219.2% | 151.19M | +12.6% | 9 |
| Next quarter | 0.0878 | 0.04 – 0.13 | 0.06 | +46.3% | 160.19M | +14.0% | 9 |
| Current year | 0.28424 | 0.25 – 0.31 | -0.11 | +358.4% | 606.26M | +13.4% | 9 |
| Next year | 0.43398 | 0.21 – 0.64 | 0.28424 | +52.7% | 680.24M | +12.2% | 9 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 21, 2026 | Citizens | Maintained | Market Outperform | Market Outperform |
| Oct 12, 2026 | BTIG | Maintained | Buy | Buy |
| Oct 2, 2026 | Freedom Capital Markets | Downgrade | Buy | Hold |
| Sep 2, 2026 | Needham | Maintained | Buy | Buy |
| Aug 27, 2026 | Piper Sandler | Maintained | Overweight | Overweight |
| Aug 24, 2026 | BTIG | Maintained | Buy | Buy |
| Jul 28, 2026 | UBS | Maintained | Buy | Buy |
| May 6, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Feb 18, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Feb 18, 2026 | UBS | Maintained | Buy | Buy |
| Feb 18, 2026 | Citizens | Maintained | Market Outperform | Market Outperform |
| Feb 18, 2026 | Oppenheimer | Downgrade | Outperform | Perform |
| Feb 18, 2026 | BTIG | Reiterated | Buy | Buy |
| Feb 12, 2026 | Needham | Reiterated | Buy | Buy |
| Dec 16, 2025 | JP Morgan | Maintained | Overweight | Overweight |
| Oct 30, 2025 | Canaccord Genuity | Maintained | Buy | Buy |
| Jul 30, 2025 | Needham | Maintained | Buy | Buy |
| Apr 30, 2025 | BTIG | Maintained | Buy | Buy |
| Apr 30, 2025 | UBS | Maintained | Buy | Buy |
| Apr 30, 2025 | JMP Securities | Reiterated | Market Outperform | Market Outperform |
| Apr 30, 2025 | Needham | Maintained | Buy | Buy |
| Apr 2, 2025 | Citizens Capital Markets | Reiterated | Market Outperform | Market Outperform |
| Mar 28, 2025 | Canaccord Genuity | Maintained | Buy | Buy |
| Mar 27, 2025 | BTIG | Maintained | Buy | Buy |
| Mar 27, 2025 | JP Morgan | Maintained | Overweight | Overweight |
| Mar 27, 2025 | Needham | Reiterated | Buy | Buy |
| Mar 21, 2025 | Needham | Reiterated | Buy | Buy |
| Feb 13, 2025 | BTIG | Maintained | Buy | Buy |
| Feb 13, 2025 | Oppenheimer | Maintained | Outperform | Outperform |
| Feb 13, 2025 | Piper Sandler | Maintained | Overweight | Overweight |